Excellent
Fully Aligned
Patient Risk:
Low
Summary
The AI claim exactly matches the provided FDA-approved Vyfemla labeling text regarding lack of protection against HIV/AIDS and other sexually transmitted diseases.
Category Scores
Accurate Statements
The product does not protect against HIV infection (AIDS) and other sexually transmitted diseases.
PRECAUTIONS, 1. Sexually Transmitted Diseases: “Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases.”; patient insert/labeling: “This product (like all oral contraceptives) is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually transmitted diseases.”
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The statement is directly supported by the provided labeling and is a counseling point rather than an incorrect or unsafe instruction.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Fully Aligned
Primary Issue
Suggested Improvement